Decibel Therapeutics (DBTX)
US Market

Decibel Therapeutics (DBTX) Stock Price & Analysis


DBTX Stock Chart & Stats

Day’s Range$4.9 - $5.11
52-Week Range― - ―
Previous Close$4.95
Average Volume (3M)N/A
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside6.92% Upside
Rating ConsensusHold
Number of Analyst Covering3


What was Decibel Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Decibel Therapeutics’s market cap?
Currently, no data Available
When is Decibel Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Decibel Therapeutics’s earnings last quarter?
Currently, no data Available
Is Decibel Therapeutics overvalued?
According to Wall Street analysts Decibel Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does Decibel Therapeutics pay dividends?
    Decibel Therapeutics does not currently pay dividends.
    What is Decibel Therapeutics’s EPS estimate?
    Decibel Therapeutics’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Decibel Therapeutics have?
    Currently, no data Available
    What happened to Decibel Therapeutics’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Decibel Therapeutics?
    Among the largest hedge funds holding Decibel Therapeutics’s share is Woodline Partners LP. It holds Decibel Therapeutics’s shares valued at N/A.


      Company Description

      Decibel Therapeutics

      Decibel Therapeutics Inc is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders. It aims to restore and improve hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support cells within the inner ear.


      Forecast EPS vs Actual EPS

      Currently, no data available
      Please return soon. This page is being updated.

      Similar Stocks
      Price & Change
      G1 Therapeutics
      Rubius Therapeutics

      Popular Stocks

      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis